Elisabeth McCauley King, M.S.N., R.N., F.N.P., A.G.N., A.O.C.N.P.

Elisabeth King, R.N., FNP, AOCNP, AGN, is a nurse practitioner and the executive director of nursing.

King joined City of Hope in 2018 from Texas Oncology where she helped lead and support the Advanced Practice Provider and Genetics programs throughout the state. She received her bachelor’s degree in biology with a focus on genetics and biotechnology from University of Texas Austin. At Austin Community College, she earned her associate's degree in nursing, and then at Frontier Nursing University she earned her master’s degree in nursing.

King is an alumnus of the City of Hope Intensive Course in Cancer Risk Assessment. She is a family nurse practitioner and also holds advanced nursing certifications in oncology and genetics.

• King, E. & Smith, E. Diversification of Nurse Practitioner Practice: Genetic Cancer Risk Assessment. The Journal for Nurse Practitioners. 2020 June 1; 16(6): 447-452.  
• King, E. & Nehoray, B. Hereditary Pancreatic Cancer Syndromes. Clinical Journal of Oncology Nursing, Clinical Journal of Oncology Nursing. 2019 Dec 1; 23(6): 579-582.
• King, E. & Nehoray, B. Evaluating TP53 Mutations in Germline Genetic Testing. Advanced Practitioner Society of Hematology and Oncology Advance. 2019, Volume 5 (1).
• Henneghan A, Stuifbergen A, Becker H, Kesler S, King E. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. Journal of Cancer Survivorship. 2017 Nov.
• King E., Mahon SM. Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes. Clinical Journal of Oncology Nursing. 2017 Oct 1;21(5):589-598.
• Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer S, Clifford J. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression. Clinical Cancer Research. 2006 Feb 1;12(3 Pt 1):969-79.
• Rundhaug J, Hawkins K, Pavone A, Gaddis S, Kil H, Klein R, Berton T, McCauley E. Johnson D, Lubet R, Fischer S, Aldaz C. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Molecular Carcinogenesis. 2005 Jan;42(1):40-52.

Poster Presentations

• King E, Patel G, Toth S, Sandbach J. The Role of Oncology Advanced Practice Providers in Genetic Cancer Risk Assessment. Oncology Nursing Society Congress Poster Session, 2016.
• Sandbach J, Patel G, King E, Evans B, Kidd J, Langer L, Brown K, Wenstrup R, Saam J. A study of triple-negative breast cancer patients tested with a 25-gene panel of hereditary cancer genes. J Clin Oncol 33, 2015 (suppl; abstr 1067).
• Cheepala S, Yin W, Trutschl M, Cvek U, Roberts J, Xu H, McCauley E, Fischer S, Clifford J. Identification of genes regulated by chemopreventive retinoids during skin cancer development: microarray analysis in-vivo. Proceedings of the American Association for Cancer Research, Volume 46, 2005.
• Muga S, Thullier P, Zhang Q, Martin P, Hudson R, Mangiante L, McCauley E. Effect of dietary conjugated linoleic acid on apoptosis and gene expression in mouse colon and human colon cancer cell lines. Proceedings of the American Association for Cancer Research, Volume 45, 2004.
• McCauley E, Anderson K, Simmons-Menchaca M, Kline K, Sanders B. Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analog, -TEA, in Human Ovarian and Cervical Cancer Cells. The University of Texas Undergraduate Research Poster Session, 90, 2004.
• Thuillier P, McCauley E, Fischer S. The tumor preventive effect of conjugated linoleic acid is PPARα-dependent: Evidence that PPARα is a tumor suppressor gene. Proceedings of the American Association for Cancer Research, Volume 44. 2003.
• McCauley E, Xu H, Sabichi A, Yang X, Steele V, Kelloff G, Lotan R, Lippman S, Fischer S, Clifford J. Retinoid receptor dependent and independent effects of potential chemopreventive phenylretinamides: mechanistic studies in-vitro and in-vivo. Proceedings of the American Association for Cancer Research, Volume 44, 2003. 
• King, E. & Dickman, E. Mind the Gap: A Professional Organization’s Approach to Bridging the Genomic Educational Gap for Oncology Nurses. Nursing, Genomics & Healthcare Conference, accepted for oral presentation, conference postponed.
• Klemp, J.R., Cohen. S., Hurley, K., Friedman, S., King, E., Senter, L., Duquette, D., dela Rama, F., Kreyling, G., Burnett, B., Shahied, Arruda. Evolving Paradigms in Germline Genetic Testing: From Risk Stratification to Test-to-Treat in Patients with Metastatic Breast Cancer (MBC). Miami Breast Conference, 2020.
• Slavin, T., Tsang, K., Longmate, J., Castillo, D., Herzog, J., Qin, H., Wang, J., Neuhausen, S., Mejia, R., King, E., Telatar, M., Marcum, C., Hendricks, C., Hake, C., Seewaldt, V., Geradts, J., Stark, J., Marcucci, G., Weitzel, J. Germline ATM mutations predispose to clonal hematopoiesis. American Society of Clinical Oncology Annual Meeting, 2019.